Arcus Biosciences Inc (NYSE:RCUS)
$ 15.27 -0.56 (-3.54%) Market Cap: 1.40 Bil Enterprise Value: 417.63 Mil PE Ratio: 0 PB Ratio: 2.47 GF Score: 79/100

Arcus Biosciences Inc at Barclays Global Healthcare Conference Transcript

Mar 17, 2022 / 02:15PM GMT
Release Date Price: $34.5 (+3.39%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

So first and foremost, it's good to see everybody back in person again after 2-year live in person. Thanks for all your support and enthusiasm for attending Barclays Biotech Conference in Miami for both investors and management team from Arcus. So up on stage, I've got Terry Rosen, CEO; and Jennifer Jarrett, COO.

Jennifer Jarrett
Arcus Biosciences, Inc. - COO & Director

Today. So today (inaudible).

Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

Today, you're the COO. Perfect. So thanks so much. And we're trying to keep this informal as possible.

Questions & Answers

Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

I think the first question for me for kind of Arcu's upcoming sort of massive data set in the second half. Before that, we make it Roche data as well in small cell lung cancer and 3 other indications. How do you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot